Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation

Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation

NLRP3 involves in the development of hepatocellular carcinoma (HCC). Eriodictyol has shown its inhibitory effect on HCC cell proliferation. However, the underlying mechanism of eriodictyol in HCC is still unclear. This study aimed to explore the effect of and mechanism of eriodictyol on HCC. In this...

Full description

Bibliographic Details
Main Authors: Wei Huang, Chenyang Wang, Hui Zhang
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Heliyon
Subjects:
Hepatocellular carcinoma
NLRP3
Eriodictyol
Metastasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024004328

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024004328

Similar Items